Avicanna Valuation
| AVCNF Stock | USD 0.25 0.04 19.05% |
Avicanna seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Avicanna from analyzing the firm fundamentals such as Return On Equity of -1.69, operating margin of (2.11) %, and Shares Outstanding of 74.52 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Avicanna's price fluctuation is out of control at this time. Calculation of the real value of Avicanna is based on 3 months time horizon. Increasing Avicanna's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avicanna otc stock is determined by what a typical buyer is willing to pay for full or partial control of Avicanna. Since Avicanna is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avicanna OTC Stock. However, Avicanna's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.21 | Hype 0.25 | Naive 0.26 |
The real value of Avicanna OTC Stock, also known as its intrinsic value, is the underlying worth of Avicanna OTC Stock, which is reflected in its stock price. It is based on Avicanna's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Avicanna's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Avicanna helps investors to forecast how Avicanna otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avicanna more accurately as focusing exclusively on Avicanna's fundamentals will not take into account other important factors: Avicanna Total Value Analysis
Avicanna is presently estimated to have takeover price of 20.15 M with market capitalization of 22.99 M, debt of 415.83 K, and cash on hands of 685.94 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Avicanna fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
20.15 M | 22.99 M | 415.83 K | 685.94 K |
Avicanna Investor Information
About 23.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.26. Avicanna had not issued any dividends in recent years. Based on the key measurements obtained from Avicanna's financial statements, Avicanna is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Avicanna Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avicanna has an asset utilization ratio of 14.66 percent. This implies that the OTC Stock is making $0.15 for each dollar of assets. An increasing asset utilization means that Avicanna is more efficient with each dollar of assets it utilizes for everyday operations.Avicanna Ownership Allocation
Avicanna holds a total of 74.52 Million outstanding shares. Avicanna retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Avicanna Profitability Analysis
The company reported the revenue of 3.27 M. Net Loss for the year was (16.77 M) with profit before overhead, payroll, taxes, and interest of 2.83 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Avicanna's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Avicanna and how it compares across the competition.
About Avicanna Valuation
The otc valuation mechanism determines Avicanna's current worth on a weekly basis. Our valuation model uses a comparative analysis of Avicanna. We calculate exposure to Avicanna's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avicanna's related companies.Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada. Avicanna operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 124 people.
8 Steps to conduct Avicanna's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Avicanna's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avicanna's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Avicanna's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Avicanna's revenue streams: Identify Avicanna's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Avicanna's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Avicanna's growth potential: Evaluate Avicanna's management, business model, and growth potential.
- Determine Avicanna's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avicanna's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Avicanna Growth Indicators
Investing in growth stocks can be very risky. If the company such as Avicanna does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 45.9 M | |
| Retained Earnings | -77.4 M |
Complementary Tools for Avicanna OTC Stock analysis
When running Avicanna's price analysis, check to measure Avicanna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avicanna is operating at the current time. Most of Avicanna's value examination focuses on studying past and present price action to predict the probability of Avicanna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avicanna's price. Additionally, you may evaluate how the addition of Avicanna to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |